Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion

Publisher： Karger

E-ISSN： 1423-0267|232|4|216-222

ISSN： 0030-3755

Source： Ophthalmologica, Vol.232, Iss.4, 2014-11, pp. : 216-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 227, Iss. 3, 2011-12 ,pp. : 132-138

Karger

Access to resources Recommend Favorite

Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion: 12-month Follow-Up and Prognostic Factors

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 207-215

Karger

Access to resources Recommend Favorite

Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema

By  

Ophthalmologica, Vol. 228, Iss. 2, 2012-06 ,pp. : 110-116

Karger

Access to resources Recommend Favorite

Exploring the Morphological and Functional Retinal Changes after Dexamethasone Intravitreal Implant (Ozurdex®) in Macular Edema due to Retinal Vein Occlusion

By  

Ophthalmic Research, Vol. 51, Iss. 3, 2014-03 ,pp. : 153-160

Karger

Access to resources Recommend Favorite